UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer

International journal of cancer, 2019-09, Vol.145 (6), p.1609-1624

2019

Volltextzugriff (PDF)

MicroRNA in Lung Cancer Metastasis

Cancers, 2019-02, Vol.11 (2), p.265

2019

Volltextzugriff (PDF)

Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C

Cancer letters, 2017-08, Vol.402, p.190-202

2017

Volltextzugriff (PDF)

ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors

Cancer letters, 2013-01, Vol.328 (1), p.144-151

2013

Volltextzugriff (PDF)

EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway

Scientific reports, 2015-09, Vol.5 (1), p.13574-13574, Article 13574

2015

Volltextzugriff (PDF)

Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor

American journal of respiratory and critical care medicine, 2011-04, Vol.183 (8), p.1071-1079

2011

Volltextzugriff (PDF)

miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway

Molecular therapy. Nucleic acids, 2020-12, Vol.22, p.471-483

2020

Volltextzugriff (PDF)

LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis

Journal of biomedical science, 2023-09, Vol.30 (1), p.1-80, Article 80

2023

Volltextzugriff (PDF)

miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44

Molecular therapy. Nucleic acids, 2024-03, Vol.35 (1), p.102091-102091, Article 102091

2024

Volltextzugriff (PDF)

MiR‐503 pleiotropically regulates epithelial‐mesenchymal transition and targets PTK7 to control lung cancer metastasis

Cancer medicine (Malden, MA), 2023-07, Vol.12 (13), p.14511-14525

2023

Volltextzugriff (PDF)

IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer

Oncotarget, 2015-04, Vol.6 (12), p.10415-10431

2015

Volltextzugriff (PDF)

Transcription Repressor Slug Promotes Carcinoma Invasion and Predicts Outcome of Patients with Lung Adenocarcinoma

Clinical cancer research, 2005-11, Vol.11 (22), p.8070-8078

2005

Volltextzugriff (PDF)

CD44s and CD44v8-10 isoforms confer acquired resistance to osimertinib by activating the ErbB3/STAT3 signaling pathway

Life sciences (1973), 2024-01, Vol.336, p.122345-122345, Article 122345

2024

Volltextzugriff (PDF)

MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process

Cancer biomarkers : section A of Disease markers, 2020-01, Vol.28 (3), p.351-363

2020

Volltextzugriff (PDF)

IGFBP7 Drives Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition in Lung Cancer

Cancers, 2019-01, Vol.11 (1), p.36

2019

Volltextzugriff (PDF)

IGFBP-7 to confer resistance to the epidermal growth factor receptor tyrosine kinase inhibitor

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e20572-e20572

2017

Volltextzugriff (PDF)

Abstract 5238: Lung adenocarcinoma harboring EGFR L858R mutation has increased invasive ability through up-regulation of CXCR4

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.5238-5238

2011

Volltextzugriff (PDF)

Abstract 625: Transcription factor slug conferring resistance To EGFR tyrosine kinase inhibitor gefitinib

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.625-625

2010

Volltextzugriff (PDF)

Correlation between Gene Expression of Aryl Hydrocarbon Receptor (AhR), Hydrocarbon Receptor Nuclear Translocator (Arnt), Cytochromes P4501A1 (CYP1A1) and 1B1 (CYP1B1), and Inducibility of CYP1A1 and CYP1B1 in Human Lymphocytes

Toxicological sciences, 2003-01, Vol.71 (1), p.20-26

2003

Volltextzugriff (PDF)

Targeting androgen receptor in bone marrow mesenchymal stem cells leads to better transplantation therapy efficacy in liver cirrhosis

Hepatology (Baltimore, Md.), 2013-04, Vol.57 (4), p.1550-1563

2013

Volltextzugriff (PDF)

Comparison of IHC, FISH and RT-PCR methods for detection of ALK rearrangements in 312 non-small cell lung cancer patients in Taiwan

PloS one, 2013-08, Vol.8 (8), p.e70839-e70839

2013

Volltextzugriff (PDF)

Perceptions of learning effectiveness in M‐learning: scale development and student awareness

Journal of computer assisted learning, 2017-10, Vol.33 (5), p.461-472

2017

Volltextzugriff (PDF)

Differential Androgen Deprivation Therapies with Anti-androgens Casodex/Bicalutamide or MDV3100/Enzalutamide versus Anti-androgen Receptor ASC-J9® Lead to Promotion versus Suppression of Prostate Cancer Metastasis

The Journal of biological chemistry, 2013-07, Vol.288 (27), p.19359-19369

2013

Volltextzugriff (PDF)

Chemopreventive Effect of Phytosomal Curcumin on Hepatitis B Virus-Related Hepatocellular Carcinoma in A Transgenic Mouse Model

Scientific reports, 2019-07, Vol.9 (1), p.10338-13, Article 10338

2019

Volltextzugriff (PDF)

Suppressive Effects of Siegesbeckia orientalis Ethanolic Extract on Proliferation and Migration of Hepatocellular Carcinoma Cells through Promoting Oxidative Stress, Apoptosis and Inflammatory Responses

Pharmaceuticals (Basel, Switzerland), 2022-07, Vol.15 (7), p.826

2022

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Englisch
(72)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer

MicroRNA in Lung Cancer Metastasis

Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C

ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors

EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway

Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor

miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway

LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis

miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44

MiR‐503 pleiotropically regulates epithelial‐mesenchymal transition and targets PTK7 to control lung cancer metastasis

IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer

Transcription Repressor Slug Promotes Carcinoma Invasion and Predicts Outcome of Patients with Lung Adenocarcinoma

CD44s and CD44v8-10 isoforms confer acquired resistance to osimertinib by activating the ErbB3/STAT3 signaling pathway

MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process

IGFBP7 Drives Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition in Lung Cancer

IGFBP-7 to confer resistance to the epidermal growth factor receptor tyrosine kinase inhibitor

Abstract 5238: Lung adenocarcinoma harboring EGFR L858R mutation has increased invasive ability through up-regulation of CXCR4

Abstract 625: Transcription factor slug conferring resistance To EGFR tyrosine kinase inhibitor gefitinib

Correlation between Gene Expression of Aryl Hydrocarbon Receptor (AhR), Hydrocarbon Receptor Nuclear Translocator (Arnt), Cytochromes P4501A1 (CYP1A1) and 1B1 (CYP1B1), and Inducibility of CYP1A1 and CYP1B1 in Human Lymphocytes

Targeting androgen receptor in bone marrow mesenchymal stem cells leads to better transplantation therapy efficacy in liver cirrhosis

Comparison of IHC, FISH and RT-PCR methods for detection of ALK rearrangements in 312 non-small cell lung cancer patients in Taiwan

Perceptions of learning effectiveness in M‐learning: scale development and student awareness

Differential Androgen Deprivation Therapies with Anti-androgens Casodex/Bicalutamide or MDV3100/Enzalutamide versus Anti-androgen Receptor ASC-J9® Lead to Promotion versus Suppression of Prostate Cancer Metastasis

Chemopreventive Effect of Phytosomal Curcumin on Hepatitis B Virus-Related Hepatocellular Carcinoma in A Transgenic Mouse Model

Suppressive Effects of Siegesbeckia orientalis Ethanolic Extract on Proliferation and Migration of Hepatocellular Carcinoma Cells through Promoting Oxidative Stress, Apoptosis and Inflammatory Responses

Suchergebnisse filtern